SCHEMBL25994609

SCHEMBL25994609

C=CCCC(C(=C)NC)N1Cc2cc(OC3CCCC3N3CC4C5CCC(C5)C4C3)ccc2C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25993020 0.74 SLC6A2 (0.33) —
SCHEMBL25993969 0.73 SLC6A2 (0.36) —
SCHEMBL25999425 0.72 OPRK1 (0.30) —
SCHEMBL26021674 0.72 PDK2 (0.33) —
SCHEMBL25993698 0.71 HRH3 (0.33) —
SCHEMBL26018954 0.71 — —
SCHEMBL25994377 0.69 — —
SCHEMBL25938098 0.66 — —
SCHEMBL25937581 0.66 — —
SCHEMBL25986702 0.59 PDE4A (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820573-B1 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASES NOVARTIS AG (CH) 2023-08-09 — — EP disclosed
Send feedback